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httpcense.Abstract Purpose: To assess the diagnostic value of magnetic resonance spectroscopy (MRS) in
the evaluation of cervical spinal cord biochemical changes in patients with cervical spondylotic mye-
lopathy (CSM).
Materials and methods: Twenty-four patients with cervical spondylotic myelopathy (patient group)
and eleven age matched neurologically free volunteers (control group) underwent magnetic reso-
nance imaging. MRS was assessed for the main metabolites including N-acetylaspartate (NAA),
Choline (Cho), Creatine (Cr) and Lactate (Lac). The MRS ﬁndings of both groups were compared.
Results: Signiﬁcant reduction in NAA/Cr ratio of patients with CSM (mean = 1.34 ± 0.09) in
comparison to controls (mean = 1.82 ± 0.08). No signiﬁcant differences in Cho/Cr ratio between
both groups. Lactate peak was detected in nine patients while it was not detected in any of the con-
trols. The difference in NAA/Cr ratio between patients with Lac peak and those without Lac peak
was insigniﬁcant.
Conclusion: MRS is a promising non invasive technique that can help to evaluate metabolic
changes of the cervical cord in cervical spondylotic myelopathy even in normally looking-areas.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Myelopathy describes any neurological deﬁcit related to the
spinal cord, cervical myelopathy results from compression of.com (T.F. Taha Ali).
tian Society of Radiology and
g by Elsevier
Radiology and Nuclear Medicine.
://dx.doi.org/10.1016/j.ejrnm.2012the spinal cord usually due to congenital cervical canal
stenosis, prolapsed inter-vertebral disc, impinging osteophyte,
ossiﬁed posterior longitudinal ligament, hypertrophic ligamen-
tum ﬂavum and dynamic instability. Cervical spondylotic mye-
lopathy (CSM) is the most common cause of spinal cord
dysfunction in the older population [1–4].
Magnetic resonance imaging (MRI) provides the greatest
range of information about osseous and soft tissue structures
for cervical myelopathy, however macrostructure of the spinal
cord was the focus of most of these studies [5–9]. Proton MR
spectroscopy (1H-MRS) is a non invasive technique that can
provide biochemical information about metabolic changes inProduction and hosting by Elsevier B.V.
.12.006
Table 1 Signiﬁcant Lac peak detection in patients and
controls.
Lac peak Patients (n= 24) Control (n= 11)
Present 9 0
Absent 15 11
Total 24 11
94 T.F. Taha Ali, A.E. Badawytissues, so it can help to elucidate the underlying pathophysiol-
ogy. 1H-MRS is often used to measure N-acetyl-aspartate
(NAA), total choline (Cho), and total creatine (Cr) [10–12].
Functional evaluation of the spinal cord using MRS had
been used in more recent studies [13–18]. It showed to have
the potential to add metabolic information to the spinal cord
MRI and improve the clinical evaluation and research investi-
gations of spinal cord diseases, such as multiple sclerosis (MS)
and intraspinal tumors. However, extensive application is still
limited because of its difﬁculty which can be attributed to mag-
netic ﬁeld inhomogeneities, physiological movements, and the
size of the anatomical region of interest (ROI) [16,18].Fig. 1 Neurologically free volunteer (a) sagittal cervical spine MR w
normal NAA/Cr ratio and no Lac peak.In the current study, we attempted to assess the diagnostic
value of 1H-MRS in evaluation of cervical spinal cord bio-
chemical changes in patients with cervical spondylotic
myelopathy.
2. Materials and methods
2.1. Patients
Our study comprised of 32 patients with clinical and radio-
graphic evidence of cervical spondylotic myelopathy who
had been referred to perform magnetic resonance imaging
(MRI). First, we excluded any patient with a history of previ-
ous cervical disc surgery (n= 4), claustrophobia (n= 2), or
those with MRI-incompatible implants (n= 2). Therefore,
remaining 24 patients (patient group) underwent MRI exami-
nation. Eleven age-matched volunteers who were neurologi-
cally free were used as controls (control group). We choose
normal volunteer as control rather than normal spinal cord re-
gions on MRI in our patient as microscopic white matter le-
sion could exist and not appear on conventional MRI.ith voxel box placed opposite to C2 level (b) MR spectra showing
Fig. 2 Patient with cervical spondylotic myelopathy (a) sagittal cervical spine MR demonstrate cord compression, voxel box is placed at
C-2 spinal cord level (b) MR spectra showing low NAA/Cr ratio with detected Lac peak.
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53 ± 11.4 years. Institutional review board approval and
informed consent were taken for all patients.
2.2. MR imaging protocol
MR imaging was performed using a 1.5-T MR (Achieva,
Philips Medical Systems, Netherland B.V.) by using a neck cir-
cular polarization surface coil. Patients were positioned in the
supine position and were informed to avoid movement during
the examination. Scout scans were taken in axial, coronal and
sagittal planes. Several sequences were done including sagittal
and axial T1-weighted images [(500–600/8–9) repetition time
msec/echo time msec] and axial and sagittal T2-weighted fast
spin echo images (3000/100) with a section thickness of 3–
4 mm, an intersection gap of 1 mm, a ﬁeld of view (FOV) of
250 mm and ﬂip angle of 90 degrees.
Magnetic resonance spectroscopy was performed for all pa-
tients and volunteers. Single voxel spectra were obtained by a
point-resolved spectroscopy (PRESS) spin-echo sequence with
the following parameters; repetition time (TR)/echo time (TE)2000/36 ms, signal acquisition 64, spectral width 1000 Hz,
number of points 512 with average scan time 4.54 min. A
three-pulse chemical shift-selective (CHESS) saturation
sequence was applied for water suppression. Very selective
suppression pulses (VSS) saturation bands were placed contig-
uously to the volume of interest (VOI) to minimize fat contam-
ination. Then the data are processed automatically. Pulse
oximeter triggering was applied in MRS sequences to reduce
the artifact attributed to spinal cord and CSF motion.
2.3. Image analysis and data interpretation
Conventional T1 and T2-weighted images were assessed for
evaluation of the macroscopic pathological changes. In
MRS, the voxel, measured 1 · 1 · 1.5–2 cm (antero-posterior,
transverse and cranio-caudal respectively) was positioned at
the C2 spinal cord level and carefully adjusted on the cord
to exclude any surrounding structures. Spectra were analyzed
for the presence of NAA (2.0 ppm), Cho (3.25 ppm), Cr
(3.03 ppm) and Lac (1.32 ppm). NAA/Cr and Cho/Cr were
recorded.
Fig. 3 Patient with cervical spondylotic myelopathy (a) sagittal cervical spine MR showing cord compression, voxel box is placed
opposite C-2 spinal cord level (b) MR spectra showing damped NAA/Cr ratio with evident Lac peak.
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The subjects were divided into two groups (patients and con-
trols). Statistical analysis was done using SPSS version 10.
The mean and standard deviation for NAA/Cho and Cho/Cr
were calculated for patients and controls and the differences
were assessed by t-test. The ﬁndings were regarded as signiﬁ-
cant if p value < 0.05.3. Results
This study included 2 groups:
Patient group: 24 patients with cervical myelopathy (15
males, 9 females; mean age 53 ± 11.4 years).
Control group: 11 age-matched neurologically free
volunteers.
A signiﬁcant Lactate peak was detected in 9 patients while
it was not detected in any of the controls (Table 1).NAA/Cr ratio in the patient group (mean = 1.34 ± 0.09)
was signiﬁcantly less than that in the control group
(mean = 1.82 ± 0.08), (t-test = 15.17, p< 0.0001) (Fig. 1).
NAA/Cr ratio in patients with Lac peak (mean = 1.31 ± 0.10)
(Figs. 2 and 3) was less than that of patients without Lac peak
(mean = 1.36 ± 0.09) (Fig. 4), however this difference was sta-
tistically insigniﬁcant (t-test = 1.32, p= 0.20) (Fig. 5).
Cho/Cr ratio in the patient group (mean = 0.82 ± 0.12)
showed no signiﬁcant difference compared to control
(mean = 0.75 ± 0.14) (t-test = 1.74, p= 0.09), also no de-
tected signiﬁcant differences in the Cho/Cr ratio between pa-
tients with Lac peak (mean = 0.80 ± 0.13) and that of
patients without Lac peak (mean 0.84 ± 0.11) (t-test = 0.74,
p= 0.47). (Tables 2 and 3) (Fig. 6).
4. Discussion
Several radiological classiﬁcation systems have been developed
to quantify the changes in signal intensity of the spinal cord in
cervical myelopathy [9,19]. However, controversy exists in the
interpretation of signal changes in the spinal cord [8,20]. This
Fig. 4 Patient with cervical spondylotic myelopathy (a) sagittal cervical spine MR with cord compression, voxel box is placed opposite
C-2 spinal cord level (b) MR spectra showing reduced NAA/Cr ratio but no Lac peak.
Fig. 5 Box plots showing NAA/Cr ratio in controls, CSM
patients without Lac peak and CSM patients with Lac peak.
Table 2 Mean NAA/Cr and Cho/Cr ratio in patient and
control groups.
No Mean NAA/Cr Mean Cho/Cr
All patients 24 1.34 ± 0.09 0.82 ± 0.12
Patients without Lactate peak 15 1.36 ± 0.09 0.84 ± 0.11
Patients with Lac peak 9 1.31 ± 0.10 0.80 ± 0.13
Controls 11 1.82 ± 0.08 0.75 ± 0.14
Table 3 t-Test and p value compared to control group.
No Mean NAA/Cr Mean Cho/Cr
t-test p value t-test p value
All patients 24 15.17 <0.0001 1.74 0.09
Patients without Lactate peak 15 14.10 <0.0001 1.89 0.07
Patients with Lac peak 9 13.33 <0.0001 0.93 0.37
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excellent information about macroscopic anatomy but limitedevaluation at microscopic and cellular function levels [16].
Metabolic information can be provided by MRS, a non
invasive technique that can detect some biochemical markers
Fig. 6 Box plots showing Cho/Cr ratio in controls, CSM
patients without Lac peak and CSM patients with Lac peak.
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(Lac). NAA is contained almost exclusively within neurons
and axons, [12,13,21,22] so it can be used as a measure of neu-
ral density and marker of normal functioning neurons as well
as neural integrity [10,11]. Choline is associated with cellular
membrane turnover and so its peak changes with altered neu-
ral membrane synthesis and degradation [12]. Creatine is rela-
tively constant as it measures global cellularity metabolic
activity, so Cr can be used as internal control [10]. Presence
of Lactate is a sign of anaerobic metabolism that may be re-
lated to inﬂammation or ischemia [23].
Cooke et al. [16] described an optimized proton spectros-
copy protocol for examination of the human cervical spinal
cord by combining ﬁeld maps and experimental data, and they
determined the metabolite concentrations in the cervical cord
in six healthy controls by short-echo point-resolved spectros-
copy (PRESS) volume localization.
The application of MRS in cord pathology seems a logical
extension of its use in the brain, but in comparison has re-
ceived relatively little attention. In preliminary study carried
out by Gomez-Anson et al. [13] and included 6 healthy volun-
teers, the mean value of NAA/Cr ratio was 1.28 ± 0.48 and
Cho/Cr was 0.45 ± 0.17 and they concluded that MRS ap-
pears potentially useful in spinal cord investigation.
In a more recent study, Marliani et al. [18] demonstrated
the feasibility of MRS – using 3T system – in obtaining main
metabolite concentration ratios in 10 healthy subjects and
showed a signiﬁcant difference between spinal cord NAA, Cr
and Cho concentration ratios in comparison to brain stem.
They concluded that: total NAA/Cr was 1.4 ± 0.3, Cho/Cr
was 0.5 ± 0.1.
MRS was used to evaluate some spinal cord pathology
especially MS, where several studies have showed that the
NAA concentration within cervical cord is reduced and
Cho/Cr is increased in MS patient in comparison with healthy
control [14,15,17,18].
In current study, NAA/Cr ratio was signiﬁcantly lower in
CSM patients (mean = 1.34 ± 0.09) in comparison to con-
trols (mean = 1.82 ± 0.08), (p< 0.0001). This can be attrib-
uted to axonal and neuronal damage even with no apparent
abnormalities at conventional MRI. This result agrees with
Holly et al. [14] who showed a trend of signiﬁcant reduction
of NAA/Cr in patients with cervical spondylotic myelopathy
in comparison to controls (1.27 vs 1.83, respectively,
p< 0.0001).
In this study, Cho/Cr ratio was not signiﬁcantly different in
patients (mean = 0.82 ± 0.12) in comparison to controls
(mean = 0.75 ± 0.14), this is in agreement with Holly et al.
[14], who also concluded that Cho/Cr ratio was not signiﬁ-
cantly different between the patient and the control groups.
In the current study nine patients with CSM had Lac peaks
(37.5%) while none of the controls showed these peaks. In the
study carried out by Holly et al. [14], they detected Lac peak in
one third of their patients with CSM while Lac peaks were not
noted in any of their controls, they explained that by the role
of cellular ischemia in the pathogenesis of CSM.
Furthermore comparison was done between patients with
Lac peaks and patients without Lac peak, this revealed that
patients with Lac peak had a lower NAA/Cr ratio
(mean = 1.31 ± 0.10) than patients without Lac peak
(mean = 1.36 ± 0.09), however the difference was not statisti-
cally signiﬁcant (p= 0.20). Regarding Cho/Cr ratio, there wasno signiﬁcant difference in its value in the case of presence or
absence of Lac peaks (p= 0.48).
Currently, MRS of the spinal cord has some potential lim-
itations which make it technically challenging. Firstly the pul-
satile ﬂow of CSF which causes the spinal cord to move
slightly with each heartbeat. The cerebrospinal ﬂuid (CSF)
that ﬂows around the cord within the spinal canal presents an-
other challenge because of the motion artifacts produced. The
relatively small cross-section of cervical cord especially in
patients with CSM presents another problem as an optimal
balance of image resolution and the volume of tissue that
can be imaged without contamination must be determined. It
is known that microstructure abnormalities were reported in
the spinal cord proximal to compression level using tensor dif-
fusion imaging [24], so, in this study, voxels were placed at the
C2 level as we thought this may reduce the artifact and im-
prove the signal-to-noise ratio which is hampered by the small
cross section of the cord.
Further improvements and advances are still to be expected
so it may be available to use smaller voxels to increase resolu-
tion and thus MRS may be used to detect changes and follow
up earlier than conventional MRI.
5. Conclusion
MRS can be used to obtain valuable information to under-
stand the microstructure and metabolic abnormalities in pa-
tients with cervical spondylotic myelopathy even in normally
looking-areas. A signiﬁcant reduction in NAA/Cr ratio in pa-
tients with CSM compared to controls, and Lac signal indi-
cates that ischemia plays a role in the pathogenesis of CSM.
A larger cohort and follow-up will be necessary to determine
whether MRS ﬁndings have prognostic signiﬁcance.
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